Sorry, you need to enable JavaScript to visit this website.

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.

Sign-up to receive all GMG announcements, including Request for Proposal (RFP) postings.

Sign Up for AlertsDetails
Title
Grant Type
Focus Area
Country
Application Due Date
HER2 Expression in Urothelial Carcinoma (UC)
Release Date:
Review Process: Pfizer Internal
Education Oncology All
Antimicrobial Resistance Testing & Stewardship to Improve Hospitalized Patients’ Health Outcomes
Release Date:
Review Process: Pfizer Internal
Translation: French (link)
Quality Improvement Hospital Benin, Congo, The Democratic Republic
Increasing Healthcare Professional Skills For COVID-19 Vaccine Discussions That Advocate Vaccination
Release Date:
Review Process: Pfizer Internal
Education Vaccines USA
Closing the Knowledge Gap in anti-TNF Cycling in Rheumatoid Arthritis
Release Date:
Review Process: Pfizer Internal
Education Inflammation & Immunology USA
Community Oncology Support for Therapy Management in Multiple Myeloma (MM)
Release Date:
Review Process: Pfizer Internal
Education Oncology USA
Management of Adults and Adolescents with Alopecia Areata
Release Date:
Review Process: Pfizer Internal
Education Inflammation & Immunology USA
Sickle Cell Disease Transition in Care
Release Date:
Partner: National Alliance of Sickle Cell Centers
Review Process: Expert Review Panel
Quality Improvement Rare Disease USA
2025 Rheumatology Fellowship – United States
Release Date:
Review Process: Expert Review Panel
Fellowship Inflammation & Immunology USA
Closing the Knowledge Gap in the Diagnosis and Management of Idiopathic Inflammatory Myopathies (IIM)
Release Date:
Review Process: Pfizer Internal
Education Inflammation & Immunology USA
Invasive Mold Diseases (IMD) & Treatment Outcomes
Release Date:
Review Process: Pfizer Internal
Research Hospital Australia, Austria, Belgium, China, France, Germany, Greece, Italy, Korea, Netherlands, Spain, Switzerland, United Kingdom
Implementing Updated RSV Immunization Recommendations for Older Adults
Release Date:
Review Process: Pfizer Internal
Education Vaccines USA
Optimization of Health IT to support RSV Immunizations
Release Date:
Review Process: Expert Review Panel
Quality Improvement Vaccines USA
Title
Grant Type
Focus Area
Country
Application Due Date
Advances in Moderate-to-Severe Atopic Dermatitis for Dermatologists and Allergists
Release Date:
Review Process: Pfizer Internal
Education Inflammation & Immunology USA
Improve the care of patients living with metastatic breast cancer
Release Date:
Partner: Rethink Breast Cancer
Review Process: Expert Review Panel
Quality Improvement Oncology Canada
Topical Hemostasis in Minimally Invasive Surgery
Release Date:
Review Process: Pfizer Internal
Education Hospital USA
Advances in Immuno-Oncology Therapy in Urothelial Cancer
Release Date:
Review Process: Pfizer Internal
Education Oncology Japan
IBD Fellow Training in US
Release Date:
Review Process: Pfizer Internal
Education Inflammation & Immunology USA
Integration of Biomarker Testing into Treatment Planning for Metastatic Colorectal Cancer
Release Date:
Partner: ACCC
Review Process: Expert Review Panel
Quality Improvement Oncology USA
Imaging Diagnostics for Differentiating Cardiac Amyloidosis
Release Date:
Review Process: Pfizer Internal
Education Rare Disease Japan
Improving Treatment Environment for Chronic Myeloid Leukemia (CML)
Release Date:
Review Process: Pfizer Internal
Education Oncology Japan
Telemedicine Initiatives for Patients with Suspected Cardiomyopathy of Unknown Cause
Release Date:
Review Process: Pfizer Internal
Education Rare Disease Japan
Quantifying the Socio-Economic Burden of Disease for Dermatology Patients and Caregivers
Release Date:
Review Process: Pfizer Internal
Research Inflammation & Immunology France, Germany, Italy, Japan, Spain, United Kingdom
Atrial Fibrillation and Venous Thromboembolism (excluding United States)
Release Date:
Partner: BMS
Review Process: Pfizer Internal
Education Internal Medicine All
China Breast Cancer Landscape – Educational Needs Assessment
Release Date:
Review Process: Pfizer Internal
Education Oncology China